Christina Furebring
Chief Operating Officer chez Strike Pharma AB
Profil
Christina Furebring is currently the Deputy Director at Atlas Therapeutics AB and A Bioscience Incentive AB.
She is also the Chief Operations Officer at Strike Pharma AB since 2022.
Previously, she worked as the Senior Vice President-Preclinical Development at Alligator Bioscience AB.
Dr. Furebring holds a doctorate degree from the University of Lund.
Postes actifs de Christina Furebring
| Sociétés | Poste | Début |
|---|---|---|
| A Bioscience Incentive AB | Corporate Officer/Principal | - |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The private company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Corporate Officer/Principal | - |
Strike Pharma AB
 Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Chief Operating Officer | 01/01/2022 |
Anciens postes connus de Christina Furebring
| Sociétés | Poste | Fin |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Corporate Officer/Principal | - |
Formation de Christina Furebring
| University of Lund | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The private company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Health Technology |
| A Bioscience Incentive AB | |
Strike Pharma AB
Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Commercial Services |
